Immunovant (IMVT) Tax Provisions (2018 - 2026)
Immunovant (IMVT) posted Tax Provisions of -$2.9 million for Q1 2026, down 284.21% on a QoQ basis from $1.6 million in Q4 2025, and down 590.39% year-over-year from $583000.0 in Q1 2025.
Immunovant (IMVT) Tax Provisions (2018 - 2026) Analysis & Trends
Immunovant's Tax Provisions history runs 9 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- Quarterly Tax Provisions fell 590.39% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (down 77.53% YoY) and the FY2026 annual result came in at $200000.0, down 77.55% from the prior year.
- Tax Provisions was -$2.9 million for Q1 2026 at Immunovant, down from $1.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at $1.6 million in Q4 2025 and bottomed at -$2.9 million in Q1 2026.
- A 5-year average of $97294.1 and a median of $232000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions slumped 8158.33% — and 2025, when it soared 1085.71%.
- Immunovant's Tax Provisions stood at $387000.0 in 2022, then sank by 127.91% to -$108000.0 in 2023, then surged by 240.74% to $152000.0 in 2024, then soared by 921.05% to $1.6 million in 2025, then slumped by 284.21% to -$2.9 million in 2026.
- Business Quant data shows IMVT's Tax Provisions at -$2.9 million in Q1 2026, $1.6 million in Q4 2025, and $594000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.86 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 913,000.00 |
| Mar 31, 2025 | 583,000.00 |
| Dec 31, 2024 | 152,000.00 |
| Sep 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | -108,000.00 |
| Sep 30, 2023 | 454,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | -991,000.00 |
| Dec 31, 2022 | 387,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 352,000.00 |
| Mar 31, 2022 | -12,000.00 |
| Sep 30, 2021 | -31,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Mar 31, 2021 | -79,000.00 |